EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

A prospective cohort study on the association between cervical microenvironmental factors and the efficacy of treating high-risk human papillomavirus infection comorbid with cervical diseases

Lingyun Ji, Jing Wu, Yang Zhou, Xiaowen Pu, Xiao Wang, Bowen Xu, Ruixian Jiao, Wenjuan Wu, Wenhong Zhang

Frontiers in Cellular and Infection Microbiology · 10.03.2026 · 16

DOI: 10.3389/fcimb.2026.1734088 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 10.03.2026. Verfasst von Lingyun Ji und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, National Medical Center for Infec…. Hauptthemen laut MEDLINE: Papillomavirus Infections, Human Papillomavirus Viruses, Cervix Uteri, Uterine Cervical Diseases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Interferon-based local therapy is an intervention for high-risk human papillomavirus (HR-HPV)-associated low-grade squamous intraepithelial lesions (LSIL) or lower-grade cervical abnormalities. This study sought to delineate the differences in clinical outcomes following interferon-based local drug treatment and elucidate the microenvironmental factors driving these disparities.

Methods

Cervical secretions, cell brush specimens, and cervical tissue samples were collected from patients with persistent HR-HPV infection and LSIL/lower-grade lesions at Shanghai First Maternity and Infant Hospital. Follow-up samples were obtained at 3 months post-treatment. Cervical secretions were subjected to 16S rRNA sequencing (to profile the microbiota) and cytokine quantification. Cell brush specimens were analyzed via transcriptome sequencing, while cervical tissue samples underwent immunohistochemical staining. Efficacy-related markers were assessed through both inter-group (independent comparisons) and intra-patient (self-paired) analyses.

Results

At the transcriptome level, the HR-HPV clearance group exhibited lower enrichment in pathways related to differentiation, keratinization, and development but higher enrichment in immune activation pathways compared to the persistence group at baseline (with a reversed pattern observed at follow-up). Baseline expression of TRAF3IP3, ZBP1 , and IFI35 was higher in the clearance group, and ZDHHC11 expression remained consistently elevated. Immunohistochemical findings further demonstrated that the percentage of TRAF3IP3- and ZBP1-positive cells at baseline was significantly higher in the clearance group than in the persistence group. At the microbial level, treatment failure was associated with reduced Lactobacillus abundance, increased Gardnerella , Streptococcus anginosus , Schaalia turicensis , and Comamonadaceae abundance, alongside higher alpha diversity. Among cervical secretory cytokines, IL-2, IL-8, IL-12p70 showed inter-group differences, while IL-4 and IL-5 were barely detectable.

Conclusions

This study characterizes the cervical microenvironmental differences underlying divergent responses to interferon-based therapy, highlighting that coordinated changes in the microenvironment and immune status modulate treatment outcomes. The upregulated mRNA and protein levels of TRAF3IP3 and ZBP1 in the baseline period favor HR-HPV clearance, suggesting their potential as promising therapeutic targets.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Papillomavirus InfectionsHuman Papillomavirus VirusesCervix UteriUterine Cervical DiseasesHumansFemaleProspective StudiesRNA, Ribosomal, 16SAdultCytokinesTreatment OutcomeMicrobiotaInterferonsChinaYoung AdultPapillomaviridaeGene Expression Profiling

Stichwörter der Autor:innen

16S rRNA gene sequencingcytokineshigh-risk human papillomavirus (HR-HPV)interferon-based local drug therapytranscriptome

Substanzen

RNA, Ribosomal, 16SCytokinesInterferons

Autor:innen und Institutionen

  • Department of Infectious Diseases, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, National Medical Center for Infectious Diseases, Huashan Hospital, State Key Laboratory of Genetic Engi…
  • Shanghai Sci-Tech Inno Center for Infection & Immunity, Shanghai, China.
  • Department of Laboratory Medicine, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China.
  • Department of Cervix, Shanghai Key Laboratory of Maternal Fetal Medicine, Shanghai Institute of Maternal-Fetal Medicine and Gynecologic Oncology, Shanghai First Maternity and Infant Hospital, School of Medicine, Tongji…
  • Department of Traditional Chinese Medicine, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China.
  • The First Affiliated Hospital of Henan Polytechnic University, The Second People's Hospital of Jiaozuo, Jiaozuo, China.

Zitieren

APA

Ji, L., Wu, J., Zhou, Y., Pu, X., Wang, X., Xu, B., Jiao, R., Wu, W., & Zhang, W. (2026). A prospective cohort study on the association between cervical microenvironmental factors and the efficacy of treating high-risk human papillomavirus infection comorbid with cervical diseases. Frontiers in Cellular and Infection Microbiology, 16. https://doi.org/10.3389/fcimb.2026.1734088

Vancouver

Ji L, Wu J, Zhou Y, Pu X, Wang X, Xu B, et al. A prospective cohort study on the association between cervical microenvironmental factors and the efficacy of treating high-risk human papillomavirus infection comorbid with cervical diseases. Frontiers in Cellular and Infection Microbiology. 2026;16. doi:10.3389/fcimb.2026.1734088

BibTeX
@article{Ji2026,
  author = {Ji, Lingyun and Wu, Jing and Zhou, Yang and Pu, Xiaowen and Wang, Xiao and Xu, Bowen and Jiao, Ruixian and Wu, Wenjuan and Zhang, Wenhong},
  title = {A prospective cohort study on the association between cervical microenvironmental factors and the efficacy of treating high-risk human papillomavirus infection comorbid with cervical diseases},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2026},
  volume = {16},
  doi = {10.3389/fcimb.2026.1734088}
}
Kostenlos starten →